Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-15,295
Closed -$1.63M 569
2023
Q1
$1.63M Buy
+15,295
New +$1.65M 0.26% 118
2022
Q4
Sell
-66,584
Closed -$5.73M 553
2022
Q3
$5.73M Buy
+66,584
New +$5.94M 1.07% 12
2021
Q1
Sell
-14,850
Closed -$1.16M 480
2020
Q4
$1.16M Sell
14,850
-23,505
-61% -$1.8M 0.42% 75
2020
Q3
$3.04M Buy
+38,355
New +$3M 1.28% 2
2020
Q1
Sell
-7,035
Closed -$611K 641
2019
Q4
$611K Buy
7,035
+3,945
+128% +$324K 0.23% 126
2019
Q3
$248K Buy
+3,090
New +$248K 0.71% 48

Other funds holding MRK

Pearl River Capital's MRK Position: Q2 2023 in Review

Pearl River Capital sold out of Merck (MRK) in Q2 2023, closing a stake of 15,295 shares — an estimated $1.63M sold.

Pearl River Capital first reported a position in MRK in Q3 2019 and held it in 6 quarters. The position peaked at $5.73M in Q3 2022. 3,255 funds tracked by Wall St. Rank hold MRK as of Q2 2023.

  • Pearl River Capital reported no remaining Merck position as of Q2 2023 after selling out during the quarter.
  • Pearl River Capital sold 15,295 Merck shares in Q2 2023, an estimated $1.63M.
  • Pearl River Capital first reported a position in Merck in Q3 2019 and held it in 6 quarters.
  • Pearl River Capital's Merck position peaked at $5.73M in Q3 2022.
  • 3,255 funds tracked by Wall St. Rank held Merck as of Q2 2023.

Based on Pearl River Capital's 13F filing for Q2 2023, filed 11 Aug 2023.